ImmunovantInc Historical Financial Ratios
IMVT Stock | USD 28.80 0.19 0.66% |
ImmunovantInc is lately reporting on over 93 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 5.79 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate ImmunovantInc financial condition quickly.
ImmunovantInc |
About ImmunovantInc Financial Ratios Analysis
ImmunovantIncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate ImmunovantInc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on ImmunovantInc financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across ImmunovantInc history.
ImmunovantInc Financial Ratios Chart
ImmunovantInc financial ratios usually calculated using numerical values taken directly from ImmunovantInc financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about ImmunovantInc. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, ImmunovantInc's Invested Capital is comparatively stable compared to the past year. Payables Turnover is likely to gain to 0.92 in 2024, whereas Free Cash Flow Yield is likely to drop (0.14) in 2024. Add Fundamental
Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Invested Capital
Invested capital represents the total cash investment that shareholders and debt holders have contributed to ImmunovantInc. There are two different methods for calculating ImmunovantInc invested capital: operating approach and financing approach. Understanding ImmunovantInc invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.Most ratios from ImmunovantInc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into ImmunovantInc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.At this time, ImmunovantInc's Invested Capital is comparatively stable compared to the past year. Payables Turnover is likely to gain to 0.92 in 2024, whereas Free Cash Flow Yield is likely to drop (0.14) in 2024.
2020 | 2021 | 2022 | 2024 (projected) | Current Ratio | 21.79 | 11.52 | 9.34 | 0.81 | Net Debt To EBITDA | 3.68 | 3.15 | 1.89 | 0.84 |
ImmunovantInc fundamentals Correlations
Click cells to compare fundamentals
ImmunovantInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ImmunovantInc Investors Sentiment
The influence of ImmunovantInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ImmunovantInc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ImmunovantInc's public news can be used to forecast risks associated with an investment in ImmunovantInc. The trend in average sentiment can be used to explain how an investor holding ImmunovantInc can time the market purely based on public headlines and social activities around ImmunovantInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ImmunovantInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ImmunovantInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ImmunovantInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ImmunovantInc.
ImmunovantInc Implied Volatility | 78.88 |
ImmunovantInc's implied volatility exposes the market's sentiment of ImmunovantInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ImmunovantInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ImmunovantInc stock will not fluctuate a lot when ImmunovantInc's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunovantInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunovantInc's short interest history, or implied volatility extrapolated from ImmunovantInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for ImmunovantInc Stock analysis
When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.